Three-Statement Breakdown
REVENUE UP
Revenue rose 3.0% year over year to $17.7B, and carried a 5.3% net margin.
REVENUE
+3.0%
17,738
GROSS PROFIT
—
—
NET INCOME
-64.5%
944
EPS (DILUTED)
-68.9%
$2.18
| Income statement | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
|
9,144 | 11,809 | 11,443 | 12,077 | 13,728 | 14,779 | 17,224 | 17,738 | +3.0% |
| SG&A |
|
(926) | (904) | (1,035) | (1,040) | (1,189) | (1,308) | (1,601) | (1,714) | +7.1% |
| Operating income |
|
491 | 1,993 | 1,519 | -1,515 | -1,177 | 2,661 | 4,081 | 1,906 | -53.3% |
| Interest expense |
|
(572) | (797) | (630) | (384) | (368) | (740) | (900) | (1,179) | +31.0% |
| Income tax |
|
-45 | (290) | (266) | -458 | -350 | (508) | (655) | (179) | -72.7% |
| Net income |
|
-54 | 928 | 636 | -1,274 | -1,227 | 1,493 | 2,659 | 944 | -64.5% |
| EPS (diluted) |
|
-$0.11 | $1.86 | $1.30 | -$2.69 | -$3.26 | $3.58 | $7.00 | $2.18 | -68.9% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-08-10 ↗